Recently, University of Alabama at Birmingham received a $1.5 million grant from NFL Charities to research a compound that is thought to alleviate some of the damages resulting from a concussion.

This new compound, catalytic oxidoreductant, was developed to help patients receiving organ donations fight rejection by the body. With the success in this realm, the compound was tired successfully on victims with nervous system injury. This continued success has lead researchers to believe it could aid in concussion victims as well, possibly preventing brain injury.

Catalytic oxidoreductant is anticipated to lessen the severity of the secondary effects associated with concussions. According to one of doctors spearheading this research, a concussion causes cell damage at the moment of impact, but then additional cells can die as a result of the brain's immune response to the inflammation.

The number of cells that die as a result of the brain's immune response is reported to account for a large and significant portion of the total sum of cells that die as the result of a concussion. Simply put, this new compound is thought to stop the immune response and stave off further cell death after a concussion. This grant will help researchers conduct trials and ascertain whether or not this could protect the brains of athletes and others susceptible to brain injury from a concussion.

Source: WKRG-TV, "UAB Gets NFL Grant to Study Concussions," Sept. 11, 2012